www.primetherapeutics.com/documents/d/primetherapeutics/glp-1a-obesity-treatment-1st-year-cost-effectiveness-study-abstract-final-7-11 Stay Informed and Connected Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and morestraight to your inbox
Mazdutide vs Retatrutide vs Other GLP-1s Its useful to place both compounds against the GLP-1 therapies that are already FDA-approved and widely prescribed: semaglutide (Wegovy/Ozempic) and tirzepatide (Zepbound/Mounjaro)
While Retatrutide has shown fewer gastrointestinal issues, it still comes with potential side effects
Loss of lean mass, most often muscle, also raises the likelihood of weakness, injuries, and falls
Improving metabolic efficiency, reducing the risk of obesity and diabetes